by Scott Larrivee | Jan 22, 2025 | News
VALENCIA, Calif. – Jan. 22, 2025 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at Piper Sandler’s Nex-Gen RadioPharma Symposium virtual event on Thursday, Jan. 23, 2025. The fireside...
by Scott Larrivee | Jan 10, 2025 | News
High-volume, breakthrough radioisotope production platform to enable innovation in life sciences and industrial applications VALENCIA, Calif. – January 10, 2025 – Nusano, a privately held physics company transforming the production of radioisotopes utilized in...
by Scott Larrivee | Nov 12, 2024 | News
VALENCIA, Calif. – November 12, 2024 – Nusano, a physics company transforming the production of radioisotopes, today announced the company’s CEO Chris Lowe will present at William Blair’s Innovators Series: Radiopharmaceuticals virtual event on Thursday, November 14,...
by Scott Larrivee | Oct 17, 2024 | News
Image above: Starget Pharma, stargetpharma.com VALENCIA, Calif. and TEL AVIV, Israel – Oct. 17, 2024 – Nusano, a physics company transforming the production of radioisotopes, and Starget Pharma, a clinical-stage biotechnology company developing precision peptide...
by Scott Larrivee | Oct 7, 2024 | News
VALENCIA, Calif. – Oct. 7, 2024 – Nusano, Inc., a physics company transforming the production of radioisotopes, today announced it will speak at three industry conferences in October 2024. Oppenheimer 2nd Annual Targeted Radiopharmaceutical Therapies in...
